Effects of tumour necrosis factor on cardiovascular disease and cancer: A two-sample Mendelian randomization study

Background: Tumour necrosis factor (TNF) inhibitors are used in the treatment of certain autoimmune diseases but given the role of TNF in tumour biology and atherosclerosis, such therapies may influence the risk of cancer and cardiovascular disease. We conducted a Mendelian randomization study to ex...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Shuai Yuan, Paul Carter, Maria Bruzelius, Mathew Vithayathil, Siddhartha Kar, Amy M. Mason, Ang Lin, Stephen Burgess, Susanna C. Larsson
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2020-09-01
Edice:	EBioMedicine
Témata:	Cancer Cardiovascular disease Tumour necrosis factor
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2352396420303327
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!